Advanced search
Start date
Betweenand

Isolation and characterization of cancer stem-cells from bone marrow samples of newly diagnosed patients with multiple myeloma

Grant number: 15/23983-5
Support type:Scholarships in Brazil - Scientific Initiation
Effective date (Start): March 01, 2016
Effective date (End): December 31, 2016
Field of knowledge:Health Sciences - Medicine - Medical Clinics
Principal researcher:Gisele Wally Braga Colleoni
Grantee:Paola Marino Dantonio
Home Institution: Escola Paulista de Medicina (EPM). Universidade Federal de São Paulo (UNIFESP). Campus São Paulo. São Paulo , SP, Brazil
Associated research grant:10/17668-6 - Identification of biomarkers and possible therapeutical targets in B-cell lymphoproliferative disorders, AP.TEM

Abstract

Multiple Myeloma (MM) is the second most prevalent hematological neoplasia in the United States. It is characterized by infiltration of tumor plasma cells in the bone marrow, synthesis of monoclonal immunoglobulins and tissue damages, such as osteolytic lesions. Despite of the progress achieved in the last decades regarding the frontline treatment for MM, this malignant neoplasia remains incurable. The possible existence of cancer stem-cells of MM (MM-CSC) explains the disease's relapse and resistance to treatments. This way, studies aiming a better characterization and comprehension of MM-CSC, focusing on finding potential therapeutic targets, are essential for developing new medications capable of promoting better survival and quality of life to the individuals affected by this disease. Thus, our intention is to identify and isolate these cancer stem-cells, which might be a potential therapeutic target for the disease.

News published in Agência FAPESP Newsletter about the scholarship:
Articles published in other media outlets (0 total):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)

Scientific publications
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
BARBOSA, REBECCA S. S.; DANTONIO, PAOLA M.; GUIMARAES, TAIS; DE OLIVEIRA, MARIANA B.; FOOK ALVES, VERUSKA L.; SANDES, ALEX FREIRE; FERNANDO, RODRIGO CARLINI; COLLEONI, GISELE W. B. Sequential combination of bortezomib and WEE1 inhibitor, MK-1775, induced apoptosis in multiple myeloma cell lines. Biochemical and Biophysical Research Communications, v. 519, n. 3, p. 597-604, NOV 12 2019. Web of Science Citations: 0.

Please report errors in scientific publications list by writing to: cdi@fapesp.br.